Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor

Journal of Obstetrics and Gynaecology Research

Volumn 33, Issue 6, 2007, Pages 810-817

  Enakpene, Christopher A ^a,b   Morhason Bello, Imran O ^a   Enakpene, Evbu O ^a   Arowojolu, Ayodele O ^a   Omigbodun, Akinyinka O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Methylergometrine; Misoprostol; Prevention; Primary post partum hemorrhage; Third stage of labor

Indexed keywords

METHYLERGOMETRINE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; FEMALE; HEMATOCRIT; HUMAN; LABOR STAGE 3; MAJOR CLINICAL STUDY; NAUSEA; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PREGNANT WOMAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SINGLE BLIND PROCEDURE; STUDENT T TEST; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADULT; FEMALE; HEMATOCRIT; HUMANS; INJECTIONS, INTRAMUSCULAR; LABOR STAGE, THIRD; METHYLERGONOVINE; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY; TIME FACTORS;

EID: 36049048276     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00661.x     Document Type: Article

References (27)

1. World Health Organization. WHO Global Estimates of Maternal Mortality for 1995: Results of an In-Depth Review, Analysis and Estimation Strategy (Statement). Geneva : The Organization, 2001.
2. Walder J. Misoprostol: preventing postpartum haemorrhage. Mod Midwife 1997 7 : 23 27.
3. Thornburg KH, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol 2000 24 : 11 14.
4. World Health Organization. WHO Mother-Baby Package. WHO/RHT/MSM/94. II. Rev. I. 9 Revision. Geneva : The Organization, 1998.
5. Centers for Disease Control and Prevention (USA). NCHS. Vital Statistics of the United States. Mortality 1985-1995, Vol. II, Part A. Atlanta : The Centers, 1997.
6. Her Majesty's Stationery Office. Report of Confidential Enquiries Into Maternal Deaths, United Kingdom 1991-1993. London : The Stationery Office, 1996.
7. Bjørnerem A, Acharya G, Øian P, Maltau JM. [Postpartum haemorrhage prophylaxis and treatment in Norway.] Tidsskr Nor Laegeforen 2002 122 : 2536 2537. (In Norwegian.)
8. Association of the British Pharmaceutical Industry. ABPI Data Sheet Compendium. London : Datapharm Publications Ltd, 1993.
9. World Health Organization. Care of the Umbilical Cord. WHO/RHT/MSM/984. Geneva : The Organization, 1998.
10. Walker JA, Hogerzeit HY. Potency of ergometrine in tropical countries. Lancet 1988 II : 393.
11. Jouppila P. Postpartum haemorrhage. Curr Opin Obstet Gynecol 1995 7 : 446 450.
12. Coombs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991 77 : 69 76.
13. Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynecol 1998 105 : 971 975.
14. Hogerzeil HV, Walker GJ. Instability of (methyl)ergometrine in tropical climates: an overview. Eur J Obstet Gynecol Reprod Biol 1996 69 : 25 29.
15. Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo controlled trial. Am J Obstet Gynecol 1998 179 : 1043 1046.
16. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997 90 : 88 92.
17. Lokugamage AU, Sullivan KR, Niculescu I et al. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage. Acta Obstet Gynecol Scand 2001 80 : 835 839.
18. Hofmeyr GJ, Walraven G, Gülmezoglu AM, Mahowana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum hemorrhage: A systematic review. BJOG 2005 112 : 547 553.
19. Villar J, Gülmezoglu AM, Hofmeyr GJ, Forma F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 2002 100 : 1301 1312.
20. Wright JM, Newton W. Is rectal misoprostol as effective as oxytocin in preventing postpartum hemorrhage? J Fam Pract 2003 52 : 281 282.
21. Derman RJ, Kodkany BS, Goudar SS et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet 2006 368 : 1248 1253.
22. DerSimonian R, Charette LJ, Mcpeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med 1982 306 : 1332 1337.
23. Lang TA, Secic M. How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers. Philadelphia : American College of Physicians, 1997 77.
24. Zuest S, Hösli I, Surbek D, Holzgreve W. Adverse effects of misoprostol in pregnancy Z Geburtshilfe Neonatol 2001 205 : 43 48. (in German).
25. Mantyla R, Kanto J. Clinical pharmacokinetics of methylergometrine. Int J Clin Pharmacol Ther Toxicol 1981 19 : 386 391.
26. Lumbiganon P, Hofmeyr J, Gülmezoglu AM, Pinol A, Villar J. Misoprostol dose-related shivering and pyrexia in the management of the third stage of labour. Br J Obstet Gynecol 1999 106 : 304 308.
27. Surbek DV, Fehr PM, Hösli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstet Gynecol 1999 94 : 255 258.